SCHEMBL12557411

SCHEMBL12557411

Cc1ccc(-c2oc3cc(C)c(I)c(C)c3c(=O)c2C)cc1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLH Q9Y253 3/20 0.47
▸ ALOX5 P09917 5/20 0.42
▸ ABCB1 P08183 3/20 0.36
▸ ADORA3 P0DMS8 2/20 0.36
▸ NOTUM Q6P988 1/20 0.35
▸ CYP3A4 P08684 4/20 0.35
▸ TDP1 Q9NUW8 4/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ KMT2A Q03164 5/20 0.33
▸ AMY1A P0DUB6 2/20 0.33
▸ PIM1 P11309 2/20 0.33
▸ CD38 P28907 2/20 0.33
▸ KDM4E B2RXH2 5/20 0.32
▸ MEN1 O00255 4/20 0.32
▸ LMNA P02545 3/20 0.32
▸ MAPT P10636 3/20 0.32
▸ RECQL P46063 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12557413 0.88 POLH (0.50) POLHALOX5ABCB1ADORA3CYP3A4
SCHEMBL25734128 0.80 POLH (0.49) POLHALOX5ADORA3NOTUMCYP3A4
SCHEMBL12557410 0.79 ALOX5 (0.44) POLHALOX5ADORA3NOTUMCYP3A4
SCHEMBL12557425 0.79 ALOX5 (0.60) ALOX5ABCB1ADORA3CYP3A4TDP1
SCHEMBL12557415 0.77 POLH (0.62) POLHALOX5ABCB1ADORA3CYP3A4
SCHEMBL13056253 0.77 POLH (0.78) POLHALOX5ABCB1ADORA3CYP3A4
SCHEMBL29187566 0.75 ALOX5 (0.43) POLHALOX5ABCB1ADORA3NOTUM
SCHEMBL12557424 0.70 ALOX5 (0.51) POLHALOX5ABCB1CYP3A4TDP1
SCHEMBL13056258 0.69 ALDH1A1 (0.71) POLHABCB1CYP3A4TDP1ALDH1A1
SCHEMBL13776268 0.69 POLH (0.82) POLHALOX5ABCB1ADORA3CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110144194-A1 CHROMENONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AXOGLIA THERAPEUTICS (LU) 2011-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144194-A1 CHROMENONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES PARK7, CDR2, SNCA POLH 4378/4885ALOX5 2924/4885ABCB1 2178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback